We certainly support clinical trials at the National Institutes of Health. In fact, the Republicans have led on this issue. In fact, Republicans have led for decades in increasing the funding for NIH, going clear back to about 1995 when then-Speaker Gingrich led an effort to double the funding for the NIH. Our colleague Mr. Upton from Michigan led the effort to dramatically increase the funding for NIH. We know that is extraordinarily important to do. Of course, while that is important, it is kind of the basic science. The real work that gets done takes that and then turns it into drugs eventually through a whole clinical trial process with lots more innovation and investment. Tragically, H.R. 3 rips $1 trillion out of that innovation funding cycle. That is why, for the life of me, I can't understand why my friends are voting for that knowing that, and how they can vote for H.R. 3 knowing that upward of 100 or more cures, lifesaving drugs, medicines never will be developed. Those aren't my numbers. Those are the numbers of the Council of Economic Advisers. Those are the numbers from CBO. They tell us in literally the next 20 years, 38 new drugs will never be developed, at a minimum, upward of 38. It could be more. I suppose it could be less. After that, it is 10 percent every year that don't get developed. We think it is actually higher than that, but those are the facts. Those are facts.…
Share
More from Greg Walden
I thank all my colleagues who came down tonight to share these words. I want to assure the American people--it feels like a eulogy--I am actually still alive but deeply indebted for their generosity, their kindness, and their words…
It does not give me pleasure to be here today to say what I am about to say. I am really frustrated. The Energy and Commerce Committee, which I am the ranking member and former chairman of, we worked most of this year on legislation to ban…
I don't have any other speakers on my side. I encourage Members to support this really important legislation, and I yield back the balance of my time.
I want to thank the gentlewoman from Delaware, my friend, for her work on this and so many other pieces of legislation and our work together. We have had a good run. There is still more work to be done in the next 40-some days, but I thank…





